Continuous Peripheral Nerve Block Catheter Market Reaches USD 681.9 Mn in 2026, Driven by Rising Surgical Procedures and Demand for Effective Postoperative Pain Management
Technological Advancements and Growing Adoption of Opioid-Sparing Regional Anesthesia to Drive Continuous Peripheral Nerve Block Catheter Market to USD 1,038.0 Mn by 2033 at 6.2% CAGR – Coherent Market Insights
Global Continuous Peripheral Nerve Block Catheter Market, by Product Type (Stimulating Catheter (Open Tip Catheter Stimulating Catheter, Closed Tip Catheter Stimulating Catheter), Non-Stimulating Catheter, (Open Tip Catheter Non-Stimulating Catheter, Closed Tip Catheter Non-Stimulating Catheter), (Over-The-Needle Catheter)) by Insertion Technique (Ultrasound, Nerve Stimulation), by Indication (Trauma Cases, Upper Extremity Surgeries, Lower Extremity Surgeries, Pain Management, Other), by End User, (Hospitals, Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 681.9 Mn in 2026 and is expected to exhibit a CAGR of 6.2% during the forecast period (2026-2033).
Increasing number of knee replacement surgeries is anticipated to drive growth of the global continuous peripheral nerve block catheter market in the forecast period. For instance, according to The Center Orthopedic and Neurosurgical Care and Research, in U.S. the number of total knee replacement surgeries is expected to increase about 3.5 million annually, by 2030. Knee surgery is expected to increase the use of nerve block catheter to reduce and manage the pain after surgery.
Market players are involved in launching new products in market, in order to increase their product portfolio. This is expected to drive growth of the global continuous peripheral nerve block catheter market. For instance, on June 13, 2022, Teleflex Incorporated, a provider of medical technologies, launchedan Arrow Pressure Injectable Midline Catheter in Australia and New Zealand. This product was launched to increase the Midline portfolio and to fulfil the expanded needs of clinicians. Arrow Pressure Injectable Midline, has bright yellow-colored hubs and labelling, which would help doctors in avoiding catheter identification mistakes.
Growing cases of fragility fractures in old age is expected to drive growth of the global continuous peripheral nerve block catheter market over the forecast period. For instance, in April 2020, according to National Center for Biotechnology Information data, it was predicted that total fragility fractures in European Union plus Sweden would increase from 2.7 million in 2017 to 3.3 million in 2030. Use of peripheral nerve block catheter is suggested to patients by doctors to reduce the pain, which would drive market of continuous peripheral nerve block catheter.
Increment in chronic pain in adult population is expected to drive growth of the global continuous peripheral nerve block catheter market over the forecast period. For instance, in 2019, according to Centers for Disease Control and Prevention data 20.4% of adults had chronic pain in U.S. Chronic pain increases with the age. For management and treatment of chronic pain peripheral nerve block catheters are used by the patients mostly above the age of 65. Old age people find it difficult to take oral drugs for pain and taking oral pain killers takes long time for recovery from pain. By using peripheral nerve block catheter for managing chronic pain, helps in fast recovery and decrease the use of oral drugs.
To know the latest trends and insights prevalent in the small molecule injectable drugs market, click the link below:
Increasing research towards the use of continuous peripheral nerve block for managing the pain is expected to drive the growth of the global continuous peripheral nerve block catheter market growth over the forecast period. For instance. In December 2021, according to National Center for Biotechnology Information’s research data the extended use of continuous peripheral nerve block resulted in decrease in postoperative pain and reduce the use of opioid after surgery. There is increase in patient satisfaction after the use of continuous peripheral nerve block catheter.
Key Takeaways of the Global Continuous Peripheral Nerve Block Catheter Market
- Global continuous peripheral nerve block catheter market is expected to exhibit a CAGR of 6.2% over the forecast period (2026-2033), owing to growth in potential markets, especially in Europe. While North America accounted for the major market share.
- By Product Type, Non-Stimulating Catheters are expected to lead with 56.0% share in 2026, supported by simpler placement, cost-effectiveness, reliability, and compatibility with ultrasound guidance. A February 2026 peer-reviewed review confirmed ultrasound improves peripheral nerve block precision, safety, and effectiveness.
- By Insertion Technique, Ultrasound-Guided placement is projected to hold 50.0% share in 2026, driven by real-time visualization of nerves, needles, tissues, and anesthetic spread. A February 2026 peer-reviewed review found ultrasound guidance improves block accuracy, success, and overall procedural safety.
- By Indication, Lower Extremity Surgeries are expected to account for 37.0% share in 2026, due to demand for analgesia after knee, hip, and trauma procedures. An April 2026 study reported lower pain scores and reduced narcotic use with catheter-based blocks.
- By Region: North America is expected to lead with 45.0% share in 2026, supported by advanced surgical infrastructure and opioid-sparing care. In 2026, CMS approved separate payment for five drugs and 11 devices qualifying as non-opioid pain treatments in outpatient and ASC settings. (Source: CMS.gov)
- Major players operating in the global continuous peripheral nerve block catheter market include Teleflex Incorporated, Braun Melsungen AG, Lepu Medical Technology Co.,Ltd., Halyard Health, Inc., ACE Medical Devices Pvt. Ltd., Ambu A/S, Epimed International Inc., Avanos Medical, Inc., Epimed, Sarstedt, Pajunk GmbH., Bard Medical, IMEDICOM, Accura Medizintechnik, Henan Tuoren Medical Device, Vygon, Scilex Holding, and ICU Medical, Inc.
Key Development
- On April 16, 2026, Eitan Medical, medical equipment supplier launched the Avoset Pain Management System in the U.S. regional anesthesia market. The system supports post-surgical peripheral nerve block infusions delivered through continuous nerve block catheters. It combines continuous basal infusion, programmable intermittent bolus and patient-controlled analgesia within one connected ambulatory pump. The offering also includes sterile tubing, patient materials, pump-return packaging and 24/7 nurse support. (Source: Eitan Medical)
Contact Us